Lean Meds review
Leanmeds describes clinician review and coaching, but its current starting offer does not identify a separate price for each molecule.
The verdict
Leanmeds now presents a general starting offer rather than the older public price ladder. Its care description is clearer than its product-level pricing: readers can see the evaluation pathway, but should request the prescribed medication and recurring amount before enrolling.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- Prescription
- Required
Leanmeds offers online weight-management evaluations and pharmacy fulfillment when a provider prescribes. The homepage describes a care coach as part of the plan.
Who writes the prescription, and what do they see?
A licensed provider reviews the assessment. The site says a live video or phone consultation occurs when state rules require it. The prescribing decision remains with that clinician.
Patients complete an online assessment before clinical review. If a prescription is issued, a licensed pharmacy handles fulfillment. The homepage advertises shipping without a separate charge and describes ongoing support.
What happens when the dose goes up?
The homepage says the price remains consistent across doses. It does not expose a current product-specific dose and price ladder before the initial health questionnaire. Ask how follow-up and dose changes are handled for the medication actually prescribed.
What the price includes
The general starting offer carries a countdown. It is not clearly assigned to semaglutide or tirzepatide on the inspected public screens. The earlier separate rates and prepayment ladder could not be reverified, so no monthly comparison is shown here.
What it claims, and what it cites
Confirm the exact molecule, formulation, dispensing pharmacy, and compounded or branded status in the proposed prescription. A generic GLP-1 offer does not establish those details for an individual patient.
Where it holds up, and where it does not
- Strength: Clinical review is described before prescribing
- Strength: Coaching is advertised within the plan
- Strength: State-dependent consultation process is explained
- Limitation: No verified current price for each molecule
- Limitation: A countdown accompanies the starting offer
- Limitation: Final medication details require confirmation
What the evidence says about this kind of treatment
The assessment above is about Lean Meds. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader prepared to clarify the exact prescription and recurring cost before committing.
- Wrong for
- Someone needing a complete public medication-by-medication price comparison.
The evidence behind what Lean Meds prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Lean Meds compares
| Seller | Who it suits | Go |
|---|---|---|
 Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | See Collective → |
 Embody | Readers who will establish the care arrangements and recurring agreement before enrollment | See Embody → |
 Trimi Health | A reader who can pay a year at once, or finance it, and wants the per-month figure to stop moving as the dose rises. | See Trimi Health → |
More GLP-1 telehealth sellers reviews: Rejuve MedsRemedy MedsREMEViRemi MedsRemote PharmacyRenlo Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Why is no Leanmeds monthly price shown?
- The current public offer is generic and time-qualified. Separate standing semaglutide and tirzepatide rates were not verified.
- Is the older prepay ladder still current?
- It did not appear in the pages inspected in October. Ask for current written terms rather than relying on the previous ladder.